Noetic
HomePurposePortfolioPeoplePerspectives

Our Portfolios

Exited

[Stealth]

Apollo Neuroscience improves your body’s resilience to stress, so you can focus, get to sleep, and stay energized.

Fund I, Fund II
Fund I, Fund II
Fund I
Fund II
Growth
Visit website
Devices & wearables
Digital health
AI/ML
Exited

[Stealth]

ASRI advances psychedelic research, continuing Dr. Shulgin's work with cutting-edge science.

Fund II
Fund II
Fund I
Fund II
Early
Visit website
Therapeutics
Exited

[Stealth]

Beckley Psytech is dedicated to helping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines.

Fund I
Fund I
Fund I
Fund II
Growth
Visit website
Therapeutics
Exited

[Stealth]

Bexson Biomedical is developing new ketamine therapies for large-market and orphan indications.

Fund I, Fund II
Fund I, Fund II
Fund I
Fund II
Growth
Visit website
Therapeutics
Exited

[Stealth]

CaaMTech leads in drug discovery and optimization, engineering psychedelics to meet modern medical standards.

Fund I, Fund II
Fund I, Fund II
Fund I
Fund II
Early
Visit website
Therapeutics
Exited

[Stealth]

Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.

Fund I
Fund I
Fund I
Fund II
IPO
Visit website
Therapeutics
Exited

[Stealth]

Cybin advances psychedelic therapeutics with innovative drug discovery, delivery, and treatment approaches to revolutionize mental healthcare.

Fund I
Fund I
Fund I
Fund II
IPO
Visit website
Therapeutics
Exited

[Stealth]

Damona Pharmaceuticals treat and prevent cognitive deficits across brain disorders and during aging.

Fund II
Fund II
Fund I
Fund II
Early
Visit website
Therapeutics
Exited

[Stealth]

Delix Therapeutics is the developer of small-molecule drug compounds intended to help provide treatment against mental disorders.

Fund I
Fund I
Fund I
Fund II
Growth
Visit website
Therapeutics
Exited

[Stealth]

Diamond develops non-hallucinogenic psychedelic treatments for widespread use, aiming to enhance mental health globally.

Fund I
Fund I
Fund I
Fund II
Growth
Visit website
Therapeutics
Exited

[Stealth]

Emergence AI is building a best-in-class agentic platform for automating, optimizing, and scaling enterprise workflows with precision and adaptability. Emergence is a d/b/a of Merlyn Mind Inc.

Fund I, Fund II
Fund I, Fund II
Fund I
Fund II
Early
Visit website
AI/ML
Exited

[Stealth]

Gilgamesh develop novel medicines that harness the therapeutic promise of psychedelics to revolutionize the treatment of mental illness.

Fund I
Fund I
Fund I
Fund II
Growth
Visit website
Therapeutics
Exited

[Stealth]

Merlyn Mind is an AI voice assistant that eliminates tech friction, allowing teachers to focus on improving student outcomes.

Fund I, Fund II
Fund I, Fund II
Fund I
Fund II
Growth
Visit website
AI/ML
Exited

[Stealth]

MindMed is a clinical-stage biotech company developing psychedelic-inspired therapies for addiction and mental illness (Psilocybin, LSD, MDMA, DMT, 18-MC). NASDAQ: MNMD; NEO: MMED.

Fund I
Fund I
Fund I
Fund II
IPO
Visit website
Therapeutics
Exited

[Stealth]

Numinus is an operating company at the forefront of addressing the growing prevalence of mental health issues and the desire for greater wellness.

Fund I
Fund I
Fund I
Fund II
IPO
Visit website
Services
Exited

[Stealth]

People Science advances research on psychedelics and alternative medicine through end-to-end clinical services.

Fund I
Fund I
Fund I
Fund II
Early
Visit website
Digital health
AI/ML
Exited

[Stealth]

PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues.

Fund I
Fund I
Fund I
Fund II
IPO
Visit website
Therapeutics
Exited

[Stealth]

Psygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications.

Fund I
Fund I
Fund I
Fund II
Early
Visit website
Therapeutics
Services
Exited

[Stealth]

Sana Health is the world's first pain and sleep management mask, aiding people around the world.

Fund I
Fund I
Fund I
Fund II
Growth
Visit website
Devices & wearables
AI/ML
Exited

[Stealth]

Tactogen is developing a next generation of gentler MDMA-like medicines to enable effective prescription mental wellness for everyone.

Fund I
Fund I
Fund I
Fund II
Early
Visit website
Therapeutics
Exited

[Stealth]

Terran aims to transform the lives of patients with neurological and psychiatricdisorders through a pipeline of next-generation therapeutics and an imaging software device.

Fund I
Fund I
Fund I
Fund II
Growth
Visit website
Therapeutics
Exited

[Stealth]

Vessel is the in-home wellness tracker that instantly and accurately uncovers what your body really needs.

Fund I
Fund I
Fund I
Fund II
Acquired
Visit website
Digital health
Exited

[Stealth]

Wake is furthering the field of fungi and plant medicine with clinical immersions and functional mushroom supplements backed by science.

Fund I
Fund I
Fund I
Fund II
Early
Visit website
Services
Exited

[Stealth]

Woven Science invests in early-stage psychedelic and wellness companies, fostering a holistic and regenerative care model.

Fund I
Fund I
Fund I
Fund II
Early
Visit website
Services
Investor Portal
/
Terms of Use
/
Privacy Policy
/
Contact
Join us for the latest updates.
Thank you for joining our community
©
<year>
Noetic
Design by Altalogy